In the United States, diagnosis of early gastric cancer is, for the most part, grossly inadequate despite availability of new and improved diagnostic means. One of the several reasons for this, in the face of the very poor results in treatment for gastric cancer, is that it has been fashionable of late to point out that the incidence of gastric cancer in the United States is reducing (meaning that it may now be relatively ignored). However, among causes of death from cancer projected for 1968, stomach cancer ranks fifth, behind lung, breast, colon, and pancreatic cancer, and ahead of rectal cancer.1 Concerning importance of early diagnosis of stomach cancer, it should be sufficient to note that the five-year survival of those with localized gastric cancer in the United States is 40%, whereas with regional involvement, a five-year survival of only 12% results.2 These figures alone establish quite a
Hoon JR. The Earlier Diagnosis of Stomach Cancer. Arch Surg. 1969;98(2):144–149. doi:10.1001/archsurg.1969.01340080036005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: